Checkpoint inhibitor-associated pneumonitis (CIP) after immunotherapy has become a challenging issue in non-small cell lung cancer (NSCLC) patients. This study leverages artificial intelligence (AI) algorithms to analyze radiomic features, aiming to predict the occurrence of CIP, as well as tumor response. This study analyzed data from 159 stage III-IV NSCLC patients undergoing immunotherapy.
View Article and Find Full Text PDF